Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Podocyte ablation Causes Acute Renal Tubule Cell Necrosis and Interstitial Fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Persistent activation of monocytes/macrophages and cell senescence in SIV-infected macaques on ART.

Frontiers in immunology·2026
Same author

Characterization of subchronic lung and brain consequences caused by mouse-adapted SARS-CoV-2 and influenza A infection of C57BL6 mice.

Frontiers in immunology·2026
Same author

Advancing dual gene therapy for SFTPC deficiency.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adults.

American journal of respiratory and critical care medicine·2026
Same author

Single-Cell RNA Sequencing Reveals Commensal Microbes Amplify Sex-Specific Immune Programming in the Murine Lung.

bioRxiv : the preprint server for biology·2026
Same journal

Genome‑wide identification of the PRN gene family in Rosaceae and the function of PbrPRN2/3 in regulating pollen tube growth.

Gene·2026
Same journal

TBX6 promotes proliferation, invasion, and migration in colorectal cancer: Integrated transcriptomic and protein interaction network analysis.

Gene·2026
Same journal

Face/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers.

Gene·2026
Same journal

Hierarchical analysis of metabolic phenotype reveals distinct microbiota and circulatory transcriptome in metabolic dysfunction-associated steatotic liver disease.

Gene·2026
Same journal

Mutation T71R enhanced the structural stability and functional activity of wild type superoxide dismutase cloned from soil metagenome.

Gene·2026
Same journal

Reduced ATXN1 expression as an adverse prognostic indicator in Acute myeloid leukemia.

Gene·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.7K

Interluekin-17A (IL17A).

Kong Chen1, Jay K Kolls1

  • 1Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh, Pittsburgh, PA, United States.

Gene
|January 26, 2017
PubMed
Summary
This summary is machine-generated.

Interleukin-17A (IL-17A) plays crucial roles in autoimmune diseases and host defense. Targeting the IL-17A pathway with biological agents has shown promise in treating conditions like psoriasis.

Keywords:
CancerInflammationInterleukin-17ANeutrophil

More Related Videos

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

11.7K
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

4.5K

Related Experiment Videos

Last Updated: Mar 8, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

35.7K
Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

11.7K
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

4.5K

Area of Science:

  • Immunology
  • Inflammation Research
  • Drug Discovery

Background:

  • Interleukin-17A (IL-17A) and IL-17A-producing cells are implicated in inflammation, autoimmune diseases, and host defense.
  • Th17 cells, a distinct CD4+ T helper cell lineage, are key producers of IL-17A and represent a potential therapeutic target.
  • The IL-17A pathway is targeted by biological agents, including those inhibiting IL-17A or its upstream regulator IL-23.

Purpose of the Study:

  • To review the discovery and fundamental roles of IL-17A.
  • To explore the receptors utilized by IL-17A.
  • To elucidate the involvement of IL-17A in mucosal immunity and inflammatory processes.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of preclinical and clinical studies involving IL-17A pathway modulation.
  • Examination of data on IL-17A's function in host defense and inflammatory conditions.

Main Results:

  • IL-17A is essential for host defense against extracellular bacteria and fungi.
  • Targeting IL-17A has proven effective, with anti-IL-17A therapy approved for psoriasis treatment.
  • IL-17A pathway inhibition is a validated therapeutic strategy for specific inflammatory diseases.

Conclusions:

  • IL-17A is a critical cytokine in immunity and inflammation, with significant implications for autoimmune diseases.
  • The IL-17A pathway represents a successful target for therapeutic intervention in various inflammatory conditions.
  • Further understanding of IL-17A's mechanisms can lead to novel treatment strategies.